AxoGen Inc. (NASDAQ:AXGN) CFO Peter J. Mariani purchased 3,333 shares of the business’s stock in a transaction on Friday, October 7th. The shares were bought at an average price of $7.50 per share, with a total value of $24,997.50. Following the purchase, the chief financial officer now directly owns 3,333 shares in the company, valued at approximately $24,997.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

AxoGen Inc. (NASDAQ:AXGN) remained flat at $8.72 during trading on Friday. The company had a trading volume of 292,026 shares. The firm’s market capitalization is $262.75 million. AxoGen Inc. has a 12 month low of $4.08 and a 12 month high of $9.88. The stock’s 50 day moving average is $8.74 and its 200 day moving average is $6.97.

AxoGen (NASDAQ:AXGN) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. Analysts anticipate that AxoGen Inc. will post ($0.40) EPS for the current year.

Insider Buying and Selling by Quarter for AxoGen (NASDAQ:AXGN)

Separately, Wedbush reiterated an “outperform” rating and set a $10.00 price target (up previously from $9.00) on shares of AxoGen in a research note on Thursday, August 4th.

Several institutional investors have recently modified their holdings of AXGN. Waddell & Reed Financial Inc. purchased a new position in shares of AxoGen during the second quarter valued at approximately $1,371,000. State Street Corp purchased a new position in shares of AxoGen during the second quarter valued at approximately $1,885,000. Rhumbline Advisers purchased a new position in shares of AxoGen during the second quarter valued at approximately $132,000. Teachers Advisors Inc. purchased a new position in shares of AxoGen during the second quarter valued at approximately $267,000. Finally, TFS Capital LLC purchased a new position in shares of AxoGen during the second quarter valued at approximately $113,000. 57.99% of the stock is owned by hedge funds and other institutional investors.

5 Day Chart for NASDAQ:AXGN

Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.